- Home
- A-Z Publications
- Current Biomarkers (Discontinued)
- Previous Issues
- Volume 6, Issue 1, 2016
Current Biomarkers (Discontinued) - Volume 6, Issue 1, 2016
Volume 6, Issue 1, 2016
-
-
A Single Use Biosensor for the Detection of Nitric Oxide (NO) at ppb and sub-μM Level in Gas-and Liquid- Phase Media
Authors: Samantha K. Butler, Freda Li, Ruchi Chaube, Dan Laskowski and Chung C. LiuNitric Oxide (NO) is an important, rapid assay biomarker of many known diseases, including asthma, chronic obstructive pulmonary disease (COPD) as well as other respiratory infections, septic shock, Parkinson's diseases and Alzheimer's dementia. Therefore, the detection and measurement of NO in a physiological fluid, either in gas or in liquid phase, are scientifically and clinically significant. The objective of this research is to d Read More
-
-
-
Treatment of Patients with Advanced Thyroid Cancer
More LessBackground: Thyroid cancers are frequent in the endocrine system especially differentiated thyroid carcinoma and 95% of all thyroid cancer cases are differentiated neoplasmas. They have a favorable prognosis; however although, a small group present recurrence in 10-15% of patients following the standard treatment, surgery and radioiodine. Medullary thyroid carcinoma which is a neoplasm of the parafollicular C cells Read More
-
-
-
Review: Circulating microRNAs in Predicting the Prognosis of Gastrointestinal Cancers
Gastrointestinal cancers remain a significant health problem worldwide. Resistance to treatment in a subset of patients is a major problem and personalized treatment is expected to improve prognosis in these individuals. Assessment of biomarkers, which are generally genes, proteins, phosphoproteins and/or microRNAs (miRNAs), and their levels in tumor or blood, leads to a view of the molecular characteristics (signat Read More
-
-
-
Trends and Topics in CD133 in Pubmed From 2000 to 2015
Authors: Pu Xia and Xiao-Yan XuBackground: CD133 is a widely used cancer stem cell marker for many cancers. Scientometric analysis is a reliable and practical method that enables us to get more information on CD133. To our knowledge, there is no bibliometric study on CD133. So, an overview of the general trend of CD133 is important for scientific researchers. Methods: In this study, data extraction was performed using the semantic search engine ‘ Read More
-
-
-
Carbonic Anhydrase Based Biomarkers: Potential Application in Human Health and Environmental Sciences
Authors: M. G. Lionetto, Roberto Caricato, M. Elena Giordano and Trifone SchettinoBackground: Carbonic anhydrase is a metalloenzyme extensively present in nature. In animals, it is involved in several functions such as respiration, pH homeostasis, salt transport, metabolic reactions, calcification, bone resorption. In recent years, the CA wide distribution, relevance in several physiological processes, involvement in several pathological conditions, as well as sensitivity to chemical pollutants has driven the resear Read More
-
-
-
Extraction, HPTLC Estimation, In silico and In vitro Evaluation of α- Amylase Inhibition Potential of Stem Bark of Terminalia arjuna
Authors: Sarita Khatkar, Arun Nanda and S. H. AnsariBackground: The problem of diabetes and associated treatments had mentioned herbal plants in several studies. The cardioactive Terminalia arjuna has also been reported for antidiabetic principles yet no scientific evidence is available. Hence, an attempt has been made by the authors to find the probable mechanism and biomarker involved for α-amylase enzyme inhibition Objective: The extraction of bark of Terminalia arj Read More
-
-
-
Inducible Nitric Oxide Synthase Expression is a Potential Marker for Acute Coronary Syndrome: A Preliminary Study
Background: In acute coronary syndrome (ACS), nitric oxide is generated in excess during ischemic attack due to marked activation of the inducible nitric oxide synthase (iNOS) enzyme by different cytokines. Consequently, serious damaging effects result. Objective: To explore the potential role of iNOS mRNA expression as a marker of acute ischemia in ACS patients and as a predictor of the attack outcome. Method: Forty-eight AC Read More
-
-
-
Bone Marker in Women with Breast Cancer
Authors: Nicole Zulauf, Gerhard M. Oremek and David GronebergSetting: We investigated the usefulness of bone markers, respectively Procollagen Type I Aminoterminal Propeptide (PINP) and Beta-Crosslaps (β-CTx) for diagnosis, treatment and monitoring of charges with histologically confirmed breast neoplasm. The intention of this project was the demonstration of the impact of the osseous fluctuation markers PINP on the one hand and β-CTx on the other hand for the verification o Read More
-
Volumes & issues
Most Read This Month
Article
content/journals/cbm
Journal
10
5
false
en
